Plasma vitamin C concentrations in patients with cystic fibrosis: Evidence of associations with lung inflammation

American Journal of Clinical Nutrition

Volumn 65, Issue 6, 1997, Pages 1858-1866

  Winklhofer Roob, Brigitte M ^a   Ellemunter, Helmut ^b   Frühwirth, Martin ^b   Schlegel Haueter, Susanna E ^b   Khoschsorur, Gholamali ^b   Van't Hof, Martin A ^b   Shmerling, David H ^b  

^a UNIVERSITY OF GRAZ   (Austria)

^b NONE

Author keywords

Cystic fibrosis; Cytokines; Free radicals; Inflammation; Malondialdehyde; Neutrophil elastase 1 proteinase inhibitor complexes; Shwachman score; Tumor necrosis factor ; Vitamin C

Indexed keywords

ASCORBIC ACID; INTERLEUKIN 6; LEUKOCYTE ELASTASE; MALONALDEHYDE; OROSOMUCOID; OXYGEN RADICAL; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; SEASONAL VARIATION; VITAMIN BLOOD LEVEL;

EID: 0030912003     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/65.6.1858     Document Type: Article

References (50)

1. Meyer KC, Zimmerman J. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis. J Lab Clin Med 1993;121:654-61.
2. Bruce MC, Poncz L, Klinger JD, Stern RC, Tomashefski JF Jr, Dearborn DG. Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am Rev Respir Dis 1985;132:529-35.
3. Yeadon M. Free radicals in lung inflammation and environmental exposure to pollutants. In: Blake D, Winyard PG, eds. Immunopharmacology of free radical species. San Diego: Academic Press, Inc. 1995:215-32.
4. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994;12:141-79.
5. Klebanoff SJ, Vadas MA, Harlan JM, et al. Stimulation of neutrophils by tumor necrosis factor. J Immunol 1986;136:4220-5.
6. Schütze S, Wiegmann K, Machleidt T, Krönke M. TNF-induced activation of NF-κB. Immunobiology 1995;193:193-203.
7. Ruef C, Jefferson DM, Schlegel-Haueter SE, Suter S. Regulation of cytokine secretion by cystic fibrosis airway epithelial cells. Eur Respir J 1993;6:1429-36.
8. 2+ and membrane potential. Arch Biochem Biophys 1987;259:457-65.
9. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A 1989;86:6377-81.
10. Halliwell B, Gutteridge JMC. The antioxidants of human extracellular fluids. Arch Biochem Biophys 1990;280:1-8.
11. Jialal I, Vega GL, Grundy SM. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis 1990;82:185-91.
12. Cross CE, van der Vliet A, O'Neill CA, Louie S, Halliwell B. Oxidants, antioxidants, and respiratory tract lining fluids. Environ Health Perspect 1994;102(suppl 10):185-91.
13. Heffner JE, Repine JE. Pulmonary strategies of antioxidant defense. Am Rev Respir Dis 1989;140:531-54.
14. Castranova V, Wright JR, Colby HD, Miles PR. Ascorbate uptake by isolated rat alveolar macrophages and type II cells. J Appl Physiol 1983;54:208-14.
15. Washko P, Rotrosen D, Levine M. Ascorbic acid in human neutrophils. Am J Clin Nutr 1991;54(suppl):1221S-7S.
16. Evans RM, Currie L, Campbell A. The distribution of ascorbic acid between various cellular components of blood, in normal individuals, and its relation to the plasma concentration. Br J Nutr 1982;47:473-82.
17. 1-protease inhibitor in vitro. Am Rev Respir Dis 1985;132:1049-54.
18. Oberritter H, Glatthaar B, Moser U, Schmidt KH. Effect of functional stimulation on ascorbate content in phagocytes under physiological and pathological conditions. Int Arch Allergy Appl Immunol 1986;81:46-50.
19. Schorah CJ, Downing C, Piripitsi A, et al. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr 1996;63:760-5.
20. Lunec J, Blake DR. The determination of dehydroascorbic acid and ascorbic acid in the serum and synovial fluid of patients with rheumatoid arthritis (RA). Free Radic Res Commun 1985;1:31-9.
21. Olusi SO, Ojutiku OO, Jessop WJE, Iboko MI. Plasma and white blood cell ascorbic acid concentrations in patients with bronchial asthma. Clin Chim Acta 1979;92:161-6.
22. Tappia PS, Troughton KL, Langley-Evans SC, Grimble RF. Cigarette smoking influences cytokine production and antioxidant defenses. Clin Sci 1995;88:485-9.
23. Langley SC, Brown RK, Kelly FJ. Reduced free-radical-trapping capacity and altered plasma antioxidant status in cystic fibrosis. Pediatr Res 1993;33:247-50.
24. Brown RK, Wyatt H, Price JF, Kelly FJ. Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress. Eur Respir J 1996;9:334-9.
25. Solomons NW, Wagonfeld JB, Rieger C, et al. Some biochemical indices of nutrition in treated cystic fibrosis patients. Am J Clin Nutr 1981;34:462-74.
26. Ramsey BW, Farrell PM, Pencharz P, Consensus Committee. Nutritional assessment and management in cystic fibrosis: a consensus report. Am J Clin Nutr 1992;55:108-16.
27. Shwachman H, Kulczycki LL. Long-term study of one hundred five patients with cystic fibrosis. Am J Dis Child 1958;96:6-15.
28. Prader A, Largo RH, Molinari L, Issler C. Physical growth of Swiss children from birth to 20 years of age. Helv Paediatr Acta Suppl 1989;52:1-125.
29. 1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral β-carotene supplementation. Pediatr Res 1996;40:130-4.
30. Winklhofer-Roob BM, Ziouzenkova O, Puhl H, et al. Impaired resistance to oxidation of low density lipoproteins in cystic fibrosis. Improvement during vitamin E supplementation. Free Radic Biol Med 1995;19:725-33.
31. Brubacher G, Vuilleumier JP. In: Curtius HC, Roth M, eds. Clinical biochemistry. Principles and methods. New York: de Gruyter, 1974:989-97.
32. Wong SHY, Knight JA, Hopfer SM, Zaharia O, Leach CN Jr, Sunderman FW Jr. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 1987;33:214-20.
33. Winklhofer-Roob BM, Puhl H, Khoschsorur G, Van't Hof MA, Esterbauer H, Shmerling DH. Enhanced resistance to oxidation of low density lipoproteins and decreased lipid peroxide formation during β-carotene supplementation in cystic fibrosis patients. Free Radic Biol Med 1995;18:849-59.
34. Hess D, Keller HE, Oberlin B, Bonfanti R, Schüep W. Simultaneous determination of retinol, tocopherols, carotenes and lycopene in plasma by means of high-performance liquid chromatography on reversed phase. Int J Vitam Nutr Res 1991;61:232-8.
35. National Research Council. Recommended dietary allowances. 10th ed. Washington, DC: National Academy Press, 1989.
36. Hercberg S, Preziosi P, Galan P, et al. Vitamin status of a healthy French population: dietary intakes and biochemical markers. Int J Vitam Nutr Res 1994;64:220-32.
37. Malvy DJM, Povéda JD, Debruyne M, et al. Laser immunonephelometry reference intervals for eight serum proteins in healthy children. Clin Chem 1992;38:394-9.
38. Kishino S, Nomura A, Zhai SD, et al. Alpha-1-acid glycoprotein concentration and the protein binding of disopyramide in healthy subjects. J Clin Pharmacol 1995;35:510-4.
39. Vanderslice JT, Higgs DJ. Vitamin C content of foods: sample variability. Am J Clin Nutr 1991:54(suppl):1323S-7S.
40. Cooney RV, Franke AA, Hankin JH, et al. Seasonal variations in plasma micronutrients and antioxidants. Cancer Epidemiol Biomarkers Prev 1995;4:207-15.
41. Khaw KT, Woodhouse P. Interrelation of vitamin C, infection, haemostatic factors, and cardiovascular disease. Br Med J 1995;310:1559-63.
42. Winklhofer-Roob BM. Oxygen free radicals and antioxidants in cystic fibrosis. The concept of an oxidant-antioxidant imbalance. Acta Paediatr Suppl 1994;395:49-57.
43. Frei B. Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage. Am J Clin Nutr 1991; 54(suppl):1113S-8S.
44. Garry PJ, Vanderjagt DJ, Hunt WC. Ascorbic acid intakes and plasma levels in healthy elderly. Ann N Y Acad Sci 1987;498:90-9.
45. Levine M, Conry-Cantilena C, Wang Y, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A 1996;93:3704-9.
46. Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988;41:583-91.
47. Rivers JM. Safety of high-level vitamin C ingestion. Ann N Y Acad Sci 1987;498:445-54.
48. Halliwell B. Vitamin C: antioxidant or pro-oxidant in vivo? Free Radic Res 1996;25:439-54.
49. Aruoma OI, Halliwell B. Superoxide-dependent and ascorbate-dependent formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Biochem J 1987;241:273-8.
50. Britigan BE, Edeker BL. Pseudomonas and neutrophil products modify transferrin and lactoferrin to create conditions that favor hydroxyl radical formation. J Clin Invest 1991;88:1092-102.